455 related articles for article (PubMed ID: 11793282)
21. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
[TBL] [Abstract][Full Text] [Related]
22. [Shortening of the measurement time by 1H-MR turbo spectroscopic imaging of the brain].
Träber F; Block W; Lamerichs R; Keller E; Schild HH
Rofo; 1997 Mar; 166(3):221-9. PubMed ID: 9156593
[TBL] [Abstract][Full Text] [Related]
23. [Brain tumors: interest of magnetic resonance spectroscopy for the diagnosis and the prognosis].
Sabatier J; Ibarrola D; Malet-Martino M; Berry I
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):858-62. PubMed ID: 11677409
[TBL] [Abstract][Full Text] [Related]
24. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
25. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Jun; 22(5):735-42. PubMed ID: 15172069
[TBL] [Abstract][Full Text] [Related]
26. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
27. Two cases of proton MR spectroscopy of the brain after irradiation.
Nakakoshi T; Matsuzawa H; Houkin K; Miyasaka K; Arimoto T
Radiat Med; 1994; 12(3):139-42. PubMed ID: 7972899
[TBL] [Abstract][Full Text] [Related]
28. [Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma].
Isobe T; Akutsu H; Yamamoto T; Shiigai M; Masumoto T; Nakai K; Takano S; Anno I; Matsumura A
No Shinkei Geka; 2011 May; 39(5):485-90. PubMed ID: 21512199
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
30. [Magnetic resonance imaging of brain tumors].
Prayer D; Brugger PC
Wien Med Wochenschr Suppl; 2002; (113):74-81. PubMed ID: 12621848
[TBL] [Abstract][Full Text] [Related]
31. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
[TBL] [Abstract][Full Text] [Related]
32. Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery.
Graves EE; Nelson SJ; Vigneron DB; Verhey L; McDermott M; Larson D; Chang S; Prados MD; Dillon WP
AJNR Am J Neuroradiol; 2001 Apr; 22(4):613-24. PubMed ID: 11290467
[TBL] [Abstract][Full Text] [Related]
33. Metabolic characteristics of intracranial metastases, detected by single-voxel proton magnetic resonance spectroscopy, are seemingly not predictive for tumor response to gamma knife radiosurgery.
Chernov M; Hayashi M; Izawa M; Nakaya K; Ono Y; Usukura M; Yoshida S; Kato K; Muragaki Y; Nakamura R; Iseki H; Hori T; Takakura K
Minim Invasive Neurosurg; 2007 Aug; 50(4):233-8. PubMed ID: 17948183
[TBL] [Abstract][Full Text] [Related]
34. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Sep; 22(7):1017-24. PubMed ID: 15288143
[TBL] [Abstract][Full Text] [Related]
35. Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors.
Herminghaus S; Pilatus U; Möller-Hartmann W; Raab P; Lanfermann H; Schlote W; Zanella FE
NMR Biomed; 2002 Oct; 15(6):385-92. PubMed ID: 12357552
[TBL] [Abstract][Full Text] [Related]
36. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
37. Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study.
Matsumura A; Isobe T; Anno I; Takano S; Kawamura H
J Clin Neurosci; 2005 May; 12(4):416-20. PubMed ID: 15925772
[TBL] [Abstract][Full Text] [Related]
38. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
[TBL] [Abstract][Full Text] [Related]
39. Proton MR spectroscopy of delayed cerebral radiation in monkeys and humans after brachytherapy.
Kinoshita K; Tada E; Matsumoto K; Asari S; Ohmoto T; Itoh T
AJNR Am J Neuroradiol; 1997 Oct; 18(9):1753-61. PubMed ID: 9367328
[TBL] [Abstract][Full Text] [Related]
40. [Preoperative radiotherapy of brain tumors].
Kondo T; Yoshioka M; Muraoka I; Tsukamoto Y; Mikuriya S; Fujii K
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1550-7. PubMed ID: 3036011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
